MedPath

AERINAZE 2,5 MG/120 MG COMPRIMIDOS DE LIBERACION MODIFICADA

AERINAZE 2,5 MG/120 MG COMPRIMIDOS DE LIBERACION MODIFICADA

Pending
Register Number

07399004IP

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Feb 19, 2020

Dosage Form

COMPRIMIDO DE LIBERACIÓN MODIFICADA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number07399004IP
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

DESLORATADINAActive
Quantity: 2,5 mg
Name: DESLORATADINA
PSEUDOEFEDRINA SULFATOActive
Quantity: 120 mg
Name: PSEUDOEFEDRINA SULFATO

ATC CLASSIFICATION (3)

R01B
R01BA
R01BA52

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.